New normal for SABA supply has begun

The Schedule 3 entry for salbutamol was updated on 1 October 2023, coinciding with a new treatment guideline around asthma relievers.

New migraine treatment approved

The TGA has approved a new preventative treatment for migraine, with a new medicine that targets the calcitonin gene-related peptide receptor. Patients experiencing migraine will...

Lack of SafeScript use linked to patient’s death

More than 3,000 S8 and diazepam tablets prescribed while RTPM was being largely ignored. While doctors were implicated, 14 pharmacists could have been too.

Changes to S3 salbutamol scheduling

Amendments to the S3 listing for salbutamol released last week will ease dispensing restrictions, hopefully reducing patient frustration and stopping unacceptable abuse experienced by some pharmacists.

Pharmacy and medical termination of pregnancy

One in six Australian pharmacists are pro-life and oppose elective termination of pregnancy. But this does not diminish their responsibilities to patients. Marie enters your...

5 changes on 1 July impacting pharmacists

All the new initiatives, funding schemes and Pharmaceutical Benefits Scheme (PBS) listings that kicked into gear on 1 July 2023.